Clinical experience with once-monthly risperidone ISM in a mental health center. A retrospective study.

被引：0
|
作者：
Merino Iglesias, A. [1 ]
Rodriguez Ortega, N. [1 ]
Montero Quer, L. [1 ]
Rodriguez Campos, M. R. [1 ]
机构：
[1] Hosp Univ Fuenlabrada, Psychiat, Madrid, Spain
来源：
EUROPEAN PSYCHIATRY | 2024年 / 67卷
关键词：
D O I：
10.1192/j.eurpsy.2024.1559
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPV0971
引用
收藏
页码：S749 / S749
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of once-monthly Risperidone ISM® in schizophrenic patients with an acute exacerbation
    Christoph U. Correll
    Robert E. Litman
    Yuriy Filts
    Jordi Llaudó
    Dieter Naber
    Ferran Torres
    Javier Martínez
    npj Schizophrenia, 6
  • [2] Efficacy and safety of once-monthly Risperidone ISM(R) in schizophrenic patients with an acute exacerbation
    Correll, Christoph U.
    Litman, Robert E.
    Filts, Yuriy
    Llaudo, Jordi
    Naber, Dieter
    Torres, Ferran
    Martinez, Javier
    NPJ SCHIZOPHRENIA, 2020, 6 (01):
  • [3] Once-monthly ibandronate: Experience from clinical practice
    Hadji, P.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S358 - S358
  • [4] Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study
    Filts, Yuriy
    Litman, Robert E.
    Martinez, Javier
    Anta, Lourdes
    Naber, Dieter
    Correll, Christoph U.
    SCHIZOPHRENIA RESEARCH, 2022, 239 : 83 - 91
  • [5] Patient-reported outcomes in schizophrenia patients treated with once-monthly extended-release risperidone in a long-term clinical study
    Dhanda, Rahul
    Varghese, Della
    Nadipelli, Vijay R.
    Fava, Maurizio
    Joshi, Namita
    Solem, Caitlyn T.
    Graham, James A.
    Learned, Susan M.
    Heidbreder, Christian
    PATIENT PREFERENCE AND ADHERENCE, 2019, 13 : 1037 - 1050
  • [6] Aripiprazole Once-monthly is Superior to Paliperidone Palmitate in a Randomized, Head-to-head Clinical Study
    Naber, D.
    Hansen, K.
    Forray, C.
    Baker, R. A.
    Sapin, C.
    Beillat, M.
    Peters-Strickland, T.
    Nylander, A. G.
    Hertel, P.
    Andersen, H. Steen
    Eramo, A.
    Loze, J. Y.
    Potkin, S.
    EUROPEAN PSYCHIATRY, 2015, 30
  • [7] Psychiatric healthcare resource utilization following initiation of aripiprazole once-monthly: a retrospective real-world study
    Waters, Heidi C.
    Touya, Maelys
    Wee, Soon Nan
    Ng, Michelle
    Thadani, Simran
    Surendran, Subina
    Renteria, Miguel
    Rush, A. John
    Patel, Rashmi
    Sarkar, Joydeep
    Fitzgerald, Heather M.
    Han, Xue
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (02) : 299 - 306
  • [8] Relapse and Treatment Adherence in Patients with Schizophrenia Switching from Paliperidone Palmitate Once-Monthly to Three-Monthly Formulation: A Retrospective Health Claims Database Analysis
    Li, Gang
    Keenan, Alexander
    Daskiran, Mehmet
    Mathews, Maju
    Nuamah, Isaac
    Orman, Camille
    Joshi, Kruti
    Singh, Arun
    Godet, Annabelle
    Pungor, Katalin
    Gopal, Srihari
    PATIENT PREFERENCE AND ADHERENCE, 2021, 15 : 2239 - 2248
  • [9] Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study (vol 239, pg 83, 2022)
    Filts, Yuriy
    Litman, Robert E.
    Martinez, Javier
    Anta, Lourdes
    Naber, Dieter
    Correll, Christoph U.
    SCHIZOPHRENIA RESEARCH, 2022, 246 : 258 - 259
  • [10] Early schizophrenia patients treated with once-monthly paliperidone palmitate over a 12-month period - a retrospective observational study
    Hargarter, L.
    Bergmans, P.
    Cherubin, P.
    Schreiner, A.
    EUROPEAN PSYCHIATRY, 2016, 33 : S251 - S251
12345